secwatch.observer — SEC 8-K summary
======================================

Issuer:     PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH)
CIK:        0001552189
Form:       8-K
Filed at:   2023-01-23T23:59:59+00:00
Accession:  0001493152-23-002132
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Panacea Life Sciences signs LOI to acquire N7 Enterprises for 22.2M shares
--------------------------------------------------------------------------

- Panacea will issue 22.2 million common shares to N7 Enterprises stockholders.
- N7 Enterprises had $4.1M revenue in FY2022 and estimated net income exceeding $1M.
- Expected close on or around February 28, 2023, subject to due diligence and definitive agreement.
- N7 operates Florida kava/kratom lounges (Lizard Juice, N7 Nitro Kava) and a distribution subsidiary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1552189/000149315223002132/0001493152-23-002132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1552189/000149315223002132/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-002132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer